Legend Biotech Corporation – Consensus ‘buy’ rating and 3.8% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Legend Biotech Corporation which can be found using ticker (LEGN) have now 9 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 90 and 65 with the average target price sitting at $75.89. Given that the stocks previous close was at $73.14 this now indicates there is a potential upside of 3.8%. Also worth taking note is the 50 day moving average now sits at $55.94 and the 200 day MA is $49.84. The company has a market capitalization of 12.70B. The stock price for Rocket Companies, Inc. is 72.75 USD

The potential market cap would be $13,180,268,469 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 0.74 and a -23.37% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search